Skip to the page

Data / Form D filings / CoapTech, Inc.

CoapTech, Inc.: Form D filings

CoapTech, Inc., a biotechnology company in Baltimore, MD, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on September 9, 2024, reports $7.1 million sold of a $13.5 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
101 West Dickman Street, Baltimore, MD, 21230
Phone
(443) 574-6934
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1823195

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 9, 2024New notice$13,500,000$7,072,474$6,427,5266Aug 27, 2024sec.gov
Jul 31, 2023New notice$5,000,000$4,000,000$1,000,0002Jun 28, 2023sec.gov
Apr 4, 2023New notice$3,000,000$785,000$2,215,0001Mar 24, 2023sec.gov
Sep 4, 2020New notice$8,000,000$7,050,000$950,00033Aug 25, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
John OsborneDirector
Howard CarolanExecutive Officer, Director
Peter BoydDirector
William WalkerDirector
Steven TropelloExecutive Officer, Director
Tim CollinsDirector
Daniel TeoDirector

Other biotechnology companies in Maryland that filed recently

Every Form D from the week of Sep 9, 2024 · All recent filings in Maryland · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what CoapTech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.